Replies to post #18845 on GeneSYS ID Inc fka GNID

[VedderMan]

Your points are noted and do make sense.

However, my group and I need to see some growth and not a reduction in PPS. We should absolutely be trading above $2. If financing news fails to bring in enough buy-side volume to get us back there, we are looking at a much longer road than originally anticipated.

Dilution does matter, even at such an insignificant amount of 5k a day when there aren't enough buyers to overcome it.

I'm long, but on the fence. I'm waiting until May to make up my mind. All I can do as an investor is base my decision on the evidence before me.

[HokieHead]

There's no market yet you are diluting, seems like you're going against the grain. I hub investors have taken their toll. They've seen their shares get cut by 200:1 and we were promised no more notes or current notes paid off in January. Now we see notes piling up regardless if they are converting or not. Definitely leaves an uneasy feeling and limits the confidence a shareholder whom has been through the ringer already can really digest.

Concerns would go away if the puzzle pieces weren't just strewn on the floor. There's nothing proving to us that a change is about to take place. Bankers, if they exist could definitely silence many but turns out to be a giant secret.

So 2016 what have we seen to build confidence, pretty much nothing.
No more Notes, we received more.
Bankers/Financing, nothing to date, it's almost May. Sales, none, it's almost May. Continuously told PPS means nothing, means a lot to me.
Bottom line nothing RXSF has stated in past has come to fruition, hence the negativity being spewed on this board.

There once was a time I looked forward to watching the board and level 2 but now I'm not happy nor sure about the future of RXSF.

I'm a long but concerned.